Tag: investors

Châtillon, France, June 2, 2026

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of Immutep Ltd. (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026, inclusive (the “Class Period”), of the important July 6, 2026 lead plaintiff deadline.

Sydney, Australia, June 02, 2026 (GLOBE NEWSWIRE) -- With the Reserve Bank of Australia cash rate at 4.35% and annual inflation running at 4.6% in the year to March 2026, self-managed super fund trustees are under pressure to find income that keeps pace with the rising cost of living. Australian Taxation Office data shows SMSF allocations to cash and deposit products have fallen to 16.3% of sector holdings, a record low, as trustees look beyond traditional cash products for the income side of the portfolio. One category drawing attention is fixed-term investment accounts underpinned by global private credit, an asset class that has reached US$3.5 trillion globally, according to the Alternative Credit Council's Financing the Economy 2025 report, and has been one of the fastest-growing asset classes in the world over the last 15+ years. To learn mroe visit https://termplus.com.au/term-account-smsf/

ISS and Glass Lewis Recognize Medallion’s Successful Business Transformation

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Qiagen N.V. (“Qiagen” or the “Company”) (NYSE: QGEN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.

ATN received $268 million in cash proceeds upon initial closing

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.